๐๐บ๐บ๐๐ป๐ถ๐๐ฎ๐๐ถ๐ผ๐ป ๐๐๐ฎ๐ฟ๐ฒ๐ป๐ฒ๐๐ ๐ ๐ผ๐ป๐๐ต ๐ถ๐ ๐ฎ ๐๐ถ๐บ๐ฒ๐น๐ ๐ฟ๐ฒ๐บ๐ถ๐ป๐ฑ๐ฒ๐ฟ ๐๐ต๐ฎ๐ ๐๐ฎ๐ฐ๐ฐ๐ถ๐ป๐ฒ๐ ๐ผ๐ป๐น๐ ๐๐ผ๐ฟ๐ธ ๐๐ต๐ฒ๐ป ๐๐ต๐ฒ๐ ๐ฟ๐ฒ๐ฎ๐ฐ๐ต ๐ฝ๐ฒ๐ผ๐ฝ๐น๐ฒ.
Coverage across the UK is falling below the 95% threshold for multiple childhood vaccines โ with Londonโs MMR uptake now under 74%. These shortfalls expose wider issues: health inequalities, system strain, and reduced confidence in prevention. But innovation is helping reset the path.
Companies like Micron Biomedical are changing how vaccines are delivered โ replacing the needle with a skin-targeted patch that simplifies storage, increases access, and removes the need for trained injection.
At Health Analytical Solutions Ltd, we work with Medtech and NHS partners to ensure innovations like these are aligned with coding, commissioning, and policy frameworks โ because delivery matters as much as discovery.